Patient Safety in Surgery Volume 2
|
Viewing options:Associated material:Related literature:- Articles citing this article
- Other articles by authors
- Related articles/pages
Tools:Post to:
|
ReviewLiver surgery in the presence of cirrhosis or steatosis: Is morbidity increased?Lucas McCormack , Pablo Capitanich and Emilio Quiñonez  Hepato-Pancreato-Biliary and Liver Transplantation Unit, General Surgery Service, Hospital Aleman, Av. Pueyrredón 1640 (1118), Ciudad Autónoma de Buenos Aires, Argentina author email corresponding author email
Patient Safety in Surgery 2008,
2:8doi:10.1186/1754-9493-2-8 Abstract
Background data
The prevalence of steatosis and hepatitis-related liver cirrhosis is dramatically increasing together worldwide. Cirrhosis and, more recently, steatosis are recognized as a clinically important feature that influences patient morbidity and mortality after hepatic resection when compared with patients with healthy liver.
Objective
To review present knowledge regarding how the presence of cirrhosis or steatosis can influence postoperative outcome after liver resection.
Methods
A critical review of the English literature was performed to provide data concerning postoperative outcome of patients presenting injured livers who required hepatectomy.
Results
In clinical studies, the presence of steatosis impaired postoperative outcome regardless the severity and quality of the hepatic fat. A great improvement in postoperative outcome has been achieved using modern and multidisciplinary preoperative workup in cirrhotic patients. Due to the lack of a proper classification for morbidity and a clear definition of hepatic failure in the literature, the comparison between different studies is very limited. Although, many surgical strategies have been developed to protect injured liver surgery, no one have gained worldwide acceptance.
Conclusion
Surgeons should take the presence of underlying injured livers into account when planning the extent and type of hepatic surgery. Preoperative and perioperative interventions should be considered to minimize the additional damage. Further randomized trials should focus on the evaluation of novel preoperative strategies to minimize risk in these patients. Each referral liver center should have the commitment to report all deaths related to postoperative hepatic failure and to use a common classification system for postoperative complications. |